Results 1 to 10 of about 36,874 (184)
A review of current knowledge of myeloproliferative disorders in the horse [PDF]
Acta Veterinaria Scandinavica, 2021 Myeloid disorders are conditions being characterized by abnormal proliferation and development of myeloid lineage including granulocytes (neutrophils, eosinophils and basophils), monocytes, erythroids, and megakaryocytes precursor cells. Myeloid leukemia,
Katy Satué +2 more
doaj +2 more sources
Chorea and Cognitive Impairment in JAK2V617F-Positive Myeloproliferative Disorders: A Case Report and Literature Review [PDF]
Medicina, 2023 Chorea is a hyperkinetic movement disorder, accompanied by dystonia, myoclonus, tics, stereotypies, and tremors. It is characterized by excessive, purposeless movements that are distressing, irregularly timed, and randomly distributed.
Ioana Butnariu +7 more
doaj +2 more sources
Hereditary myeloproliferative disorders
Haematologica, 2010 Hereditary forms of myeloproliferative disorders (MPD) can be divided into two broad categories. First, inherited syndromes that affect a single lineage with Mendelian inheritance, high penetrance and polyclonal hematopoiesis, and second, inherited predisposition to true MPD, characterized by ...
Radek C. Skoda
doaj +4 more sources
Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders [PDF]
Cells, 2021 Platelets are conventionally defined as playing a vital role in homeostasis and thrombosis. This role has over the years transformed as knowledge regarding platelets has expanded to include inflammation, cancer progression, and metastasis.
Lisa Repsold, Anna Margaretha Joubert
doaj +2 more sources
Myelodysplastic/myeloproliferative disorders
Haematologica, 2008 Most patients with myelodysplastic syndromes present with anemia, while neutropenia, thrombocytopenia, or both may be found initially or may appear later.[1][1] Therefore cytopenia, frequently pancytopenia (i.e., reduced counts of red blood cells, white blood cells and platelets in peripheral ...
Luca Malcovati, Mario Cazzola
doaj +4 more sources
Eosinophilic myeloproliferative disorders. [PDF]
Hematology Am Soc Hematol Educ Program, 2011 AbstractDespite recent attempts to define and classify patients with marked eosinophilia and features consistent with myeloproliferative disease, areas of controversy remain. These are particularly apparent in situations in which multiple lineages are involved in a clonal process and clinical manifestations are overlapping. Although the introduction of
Klion AD.
europepmc +5 more sources
Myelodysplastic and myeloproliferative disorders of childhood. [PDF]
Hematology Am Soc Hematol Educ Program, 2016 AbstractMyelodysplastic syndrome (MDS) and myeloproliferative disorders are rare in children; they are divided into low-grade MDS (refractory cytopenia of childhood [RCC]), advanced MDS (refractory anemia with excess blasts in transformation), and juvenile myelomonocytic leukemia (JMML), each with different characteristics and management strategies ...
Hasle H.
europepmc +6 more sources
Pulmonary hypertension in patients with chronic myeloproliferative disorders [PDF]
European Respiratory Review, 2015 Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary ...
Yochai Adir, Davide Elia, Sergio Harari
doaj +2 more sources
IL-4 Serum Level Estimation in Myeloproliferative Neoplasm Patients
مجلة مركز بحوث التقنيات الاحيائية, 2022 Back Ground: Myeloproliferative neoplasm (MPN) is a long-term blood disease that has an excess production of mature hematopoietic pluripotent stem cells in the bone marrow. In the early fifties, W.
Ahmed Rushdi Abdullah
doaj +1 more source
Pathogenesis of Myeloproliferative Disorders [PDF]
Annual Review of Pathology: Mechanisms of Disease, 2016 Myeloproliferative neoplasms (MPNs) are a set of chronic hematopoietic neoplasms with overlapping clinical and molecular features. Recent years have witnessed considerable advances in our understanding of their pathogenetic basis. Due to their protracted clinical course, the evolution to advanced hematological malignancies, and the accessibility of ...
Nangalia, J, Grinfeld, J, Green, AR
openaire +4 more sources